Related Experiment Video
Updated: Dec 31, 2025
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
The microenvironment in myeloma
Oliver C Lomas1,2,3, Sabrin Tahri1,2,3, Irene M Ghobrial1,2,3
1Dana-Farber Cancer Institute, Boston.
Purpose Of Review:
The aim of the review is to describe recent advances in our understanding of how multiple myeloma interacts with its cellular and molecular neighbours in the bone marrow microenvironment, and how this may provide targets for prognostication and prevention.
Recent Findings:
The bone marrow microenvironment in myeloma is beginning to yield targets that are amenable to therapy. A number of trials demonstrate some clinical efficacy in heavily pretreated disease. The challenge remains for how and when these therapeutic interventions are of particular benefit early in disease progression.
Summary:
Multiple myeloma is rarely curable and its interactions with the bone marrow microenvironment are evident. However, separating cause from effect remains a challenge. We propose that targeting specific niches within the bone marrow will yield therapies that have the potential for significant benefit in myeloma and may facilitate earlier intervention to disrupt an environment that is permissive for myeloma progression.
Insights
Recent advances reveal how multiple myeloma interacts with the bone marrow microenvironment. Targeting specific bone marrow niches may offer new therapies for earlier intervention in multiple myeloma.
Area of Science:
- Hematology
- Oncology
- Cancer Biology
Background:
- Multiple myeloma is a hematologic malignancy characterized by complex interactions within the bone marrow microenvironment.
- Understanding these interactions is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To review recent advancements in understanding the interplay between multiple myeloma and its bone marrow microenvironment.
- To identify potential therapeutic and prognostic targets within this microenvironment for multiple myeloma.
Main Methods:
- Review of current scientific literature on multiple myeloma and bone marrow microenvironment interactions.
- Analysis of emerging therapeutic targets and their clinical efficacy in ongoing trials.
Main Results:
- The bone marrow microenvironment in multiple myeloma presents several targets amenable to therapy.
- Current therapeutic interventions show some clinical efficacy, particularly in heavily pretreated patients.
- A key challenge is determining the optimal timing for these interventions early in disease progression.
Conclusions:
- Targeting specific niches within the bone marrow microenvironment holds promise for significant therapeutic benefit in multiple myeloma.
- Such targeted therapies may facilitate earlier intervention, disrupting the progression-permissive environment.
- Further research is needed to delineate cause-and-effect relationships and optimize early-stage treatment strategies.
